Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

240 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The mechanisms of alloxan- and streptozotocin-induced diabetes.
Lenzen S. Lenzen S. Diabetologia. 2008 Feb;51(2):216-26. doi: 10.1007/s00125-007-0886-7. Epub 2007 Dec 18. Diabetologia. 2008. PMID: 18087688 Review.
Effects of various modifiers of insulin release on the lanthanum-nondisplaceable 45Ca2+ uptake by isolated pancreatic islets.
Hellman B, Lenzen S, Sehlin J, Täljedal IB. Hellman B, et al. Among authors: lenzen s. Diabetologia. 1977 Jan;13(1):49-53. doi: 10.1007/BF00996327. Diabetologia. 1977. PMID: 190076
Inhibition of insulin and glucagon release from the perfused rat pancreas by cyproheptadine (Periactinol, Nuran).
Joost HG, Beckmann J, Holze S, Lenzen S, Poser W, Hasselblatt A. Joost HG, et al. Among authors: lenzen s. Diabetologia. 1976 Jul;12(3):201-6. doi: 10.1007/BF00422086. Diabetologia. 1976. PMID: 782991
Effects of alloxan and ninhydrin on mitochondrial Ca2+ transport.
Lenzen S, Brünig H, Münster W. Lenzen S, et al. Mol Cell Biochem. 1992 Dec 16;118(2):141-51. doi: 10.1007/BF00299393. Mol Cell Biochem. 1992. PMID: 1293509
Thiol-group reactivity, hydrophilicity and stability of alloxan, its reduction products and its N-methyl derivatives and a comparison with ninhydrin.
Lenzen S, Munday R. Lenzen S, et al. Biochem Pharmacol. 1991 Sep 12;42(7):1385-91. doi: 10.1016/0006-2952(91)90449-f. Biochem Pharmacol. 1991. PMID: 1930261
Alloxan and ninhydrin inhibition of hexokinase from pancreatic islets and tumoural insulin-secreting cells.
Lenzen S, Freytag S, Panten U, Flatt PR, Bailey CJ. Lenzen S, et al. Pharmacol Toxicol. 1990 Mar;66(3):157-62. doi: 10.1111/j.1600-0773.1990.tb00725.x. Pharmacol Toxicol. 1990. PMID: 2185463
Alloxan: history and mechanism of action.
Lenzen S, Panten U. Lenzen S, et al. Diabetologia. 1988 Jun;31(6):337-42. doi: 10.1007/BF02341500. Diabetologia. 1988. PMID: 3046975 Review. No abstract available.
Inhibition of glucokinase by alloxan through interaction with SH groups in the sugar-binding site of the enzyme.
Lenzen S, Freytag S, Panten U. Lenzen S, et al. Mol Pharmacol. 1988 Sep;34(3):395-400. Mol Pharmacol. 1988. PMID: 3419426
Regulation of energy metabolism in pancreatic islets by glucose and tolbutamide.
Panten U, Zünkler BJ, Scheit S, Kirchhoff K, Lenzen S. Panten U, et al. Among authors: lenzen s. Diabetologia. 1986 Sep;29(9):648-54. doi: 10.1007/BF00869265. Diabetologia. 1986. PMID: 3539682
Effects of glucose refeeding and glibenclamide treatment on glucokinase and GLUT2 gene expression in pancreatic B-cells and liver from rats.
Tiedge M, Lenzen S. Tiedge M, et al. Among authors: lenzen s. Biochem J. 1995 May 15;308 ( Pt 1)(Pt 1):139-44. doi: 10.1042/bj3080139. Biochem J. 1995. PMID: 7755556 Free PMC article.
240 results
Jump to page
Feedback